• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外显子组测序确定凝溶胶蛋白突变是遗传性延髓起病神经病的病因。

Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar-onset neuropathy.

作者信息

Caress James B, Johnson Janel O, Abramzon Yevgeniya A, Hawkins Gregory A, Gibbs J Raphael, Sullivan Elizabeth A, Chahal Chamanpreet S, Traynor Bryan J

机构信息

Department of Neurology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, North Carolina, 27157, USA.

Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Muscle Nerve. 2017 Nov;56(5):1001-1005. doi: 10.1002/mus.25550. Epub 2017 Mar 23.

DOI:10.1002/mus.25550
PMID:28039894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5494018/
Abstract

INTRODUCTION

Progressive bulbar motor neuropathy is primarily caused by bulbar-onset ALS. Hereditary amyloidosis type IV also presents with a bulbar neuropathy that mimics motor neuron disease. The disease is prevalent in Finland only and is not commonly included in the differential diagnosis of ALS.

METHODS

We studied 18 members of a family in which some had bulbar motor neuropathy, and we performed exome sequencing.

RESULTS

Five affected family members were found to have a D187Y substitution in the GSN gene known to cause hereditary amyloidosis type IV.

CONCLUSIONS

This American family presented with progressive bulbar neuropathy due to a gelsolin mutation not found in Finland. Hereditary amyloidosis type IV presents with bulbar motor neuropathy and not with peripheral neuropathy as occurs with common forms of amyloidosis. This report demonstrates the power of exome sequencing to determine the cause of rare hereditary diseases with incomplete or atypical phenotypes. Muscle Nerve 56: 1001-1005, 2017.

摘要

引言

进行性延髓运动神经病主要由延髓起病的肌萎缩侧索硬化症(ALS)引起。IV型遗传性淀粉样变性也表现为类似运动神经元病的延髓神经病。该疾病仅在芬兰流行,在ALS的鉴别诊断中通常不被考虑。

方法

我们研究了一个家族中的18名成员,其中一些人患有延髓运动神经病,并进行了外显子组测序。

结果

发现5名受影响的家庭成员在已知会导致IV型遗传性淀粉样变性的GSN基因中有D187Y替代。

结论

这个美国家族因在芬兰未发现的凝溶胶蛋白突变而出现进行性延髓神经病。IV型遗传性淀粉样变性表现为延髓运动神经病,而非常见淀粉样变性形式所出现的周围神经病。本报告证明了外显子组测序在确定具有不完全或非典型表型的罕见遗传性疾病病因方面的作用。《肌肉与神经》56: 1001 - 1005, 2017年。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/5494018/947165303746/nihms840037f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/5494018/1258fb133917/nihms840037f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/5494018/947165303746/nihms840037f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/5494018/1258fb133917/nihms840037f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/5494018/947165303746/nihms840037f2.jpg

相似文献

1
Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar-onset neuropathy.外显子组测序确定凝溶胶蛋白突变是遗传性延髓起病神经病的病因。
Muscle Nerve. 2017 Nov;56(5):1001-1005. doi: 10.1002/mus.25550. Epub 2017 Mar 23.
2
Hereditary gelsolin amyloidosis (HGA): a neglected cause of bilateral progressive or recurrent facial palsy.遗传性凝溶胶蛋白淀粉样变性(HGA):双侧进行性或复发性面瘫的一个被忽视的病因。
J Peripher Nerv Syst. 2017 Mar;22(1):59-63. doi: 10.1111/jns.12200.
3
Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel Variant p.Glu580Lys.与新型变体 p.Glu580Lys 相关的凝胶蛋白淀粉样变性的临床和组织病理学特征。
Int J Mol Sci. 2021 Jan 22;22(3):1084. doi: 10.3390/ijms22031084.
4
The First Korean Family With Hereditary Gelsolin Amyloidosis Caused by p.D214Y Mutation in the GSN Gene.首个因GSN基因p.D214Y突变导致遗传性凝溶胶蛋白淀粉样变性的韩裔家族。
Ann Lab Med. 2016 May;36(3):259-62. doi: 10.3343/alm.2016.36.3.259.
5
Danish type gelsolin-related amyloidosis in a Brazilian family: case reports.巴西一个家族中的丹麦型凝溶胶蛋白相关淀粉样变性:病例报告。
Arq Bras Oftalmol. 2011 Jul-Aug;74(4):286-8. doi: 10.1590/s0004-27492011000400012.
6
[Hereditary gelsolin amyloidosis--40 years of Meretoja disease].[遗传性凝溶胶蛋白淀粉样变性——梅雷托亚病40年]
Duodecim. 2010;126(10):1162-71.
7
[Neurological manifestations of AGel amyloidosis (Meretoja's syndrome) in a German family].[一个德国家庭中AGel淀粉样变性(梅雷托亚综合征)的神经学表现]
Fortschr Neurol Psychiatr. 2011 Apr;79(4):238-41. doi: 10.1055/s-0029-1246083. Epub 2011 Apr 8.
8
Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred.一种新型的凝胶蛋白变体导致一个大家族的肾病综合征和肾淀粉样变性。
Amyloid. 2014 Jun;21(2):110-2. doi: 10.3109/13506129.2014.891502. Epub 2014 Mar 6.
9
Hereditary gelsolin amyloidosis mimicking Sjögren's syndrome.模仿干燥综合征的遗传性凝溶胶蛋白淀粉样变性
Clin Rheumatol. 2009 Nov;28(11):1351-4. doi: 10.1007/s10067-009-1260-6. Epub 2009 Aug 23.
10
Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.临床、组织病理学和计算机分析揭示一个芬兰型家族性淀粉样变性(梅雷托哈综合征)家系的致病突变:一种新型的原肌球蛋白基因突变。
Mol Vis. 2020 May 2;26:345-354. eCollection 2020.

引用本文的文献

1
Gelsolin variant amyloidosis mimicking progressive bulbar palsy.模仿进行性延髓麻痹的凝溶胶蛋白变体淀粉样变性
Muscle Nerve. 2022 Nov;66(5):E28-E30. doi: 10.1002/mus.27714. Epub 2022 Sep 21.
2
Clinical Features and Brain MRI Findings in Korean Patients with AGel Amyloidosis.韩国载脂蛋白 E 淀粉样变性患者的临床特征和脑 MRI 表现。
Yonsei Med J. 2021 May;62(5):431-438. doi: 10.3349/ymj.2021.62.5.431.
3
Analyses Mutations in , and Genes in Chinese Patients With Alzheimer's Disease.中国阿尔茨海默病患者中、和基因的突变分析。
Front Aging Neurosci. 2020 Sep 10;12:581524. doi: 10.3389/fnagi.2020.581524. eCollection 2020.
4
Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.芬兰肌球蛋白相关蛋白淀粉样变性导致严重疾病负担,但不影响生存:FIN-GAR 二期研究。
Orphanet J Rare Dis. 2020 Jan 17;15(1):19. doi: 10.1186/s13023-020-1300-5.
5
Common origin of the gelsolin gene variant in 62 Finnish AGel amyloidosis families.62 个芬兰家族性淀粉样变性伴肌球蛋白轻链基因突变的共同来源。
Eur J Hum Genet. 2018 Jan;26(1):117-123. doi: 10.1038/s41431-017-0026-x. Epub 2017 Nov 22.

本文引用的文献

1
Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives.角膜营养不良的特征:从临床、组织学和遗传学角度的综述
Int J Ophthalmol. 2016 Jun 18;9(6):904-13. doi: 10.18240/ijo.2016.06.20. eCollection 2016.
2
Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker.转甲状腺素蛋白家族性淀粉样多发性神经病中的舌萎缩和束颤:ALS 类拟病。
Neurol Genet. 2015 Jul 30;1(2):e18. doi: 10.1212/NXG.0000000000000018. eCollection 2015 Aug.
3
Progressive cranial nerve involvement and grading of facial paralysis in gelsolin amyloidosis.凝溶胶蛋白淀粉样变性中进行性颅神经受累及面神经麻痹分级
Muscle Nerve. 2016 May;53(5):762-9. doi: 10.1002/mus.24922. Epub 2016 Feb 26.
4
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
5
UK gears up to decode 100,000 genomes from NHS patients.英国准备对来自国民医疗服务体系(NHS)患者的10万个基因组进行解码。
Lancet. 2015 Jan 10;385(9963):103-4. doi: 10.1016/S0140-6736(14)62453-3.
6
Clinical exome performance for reporting secondary genetic findings.用于报告次要基因发现的临床外显子组表现。
Clin Chem. 2015 Jan;61(1):213-20. doi: 10.1373/clinchem.2014.231456. Epub 2014 Nov 20.
7
Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy.转甲状腺素蛋白家族性淀粉样多神经病诊断与管理的最新进展
J Neurol. 2014 Jun;261(6):1227-33. doi: 10.1007/s00415-014-7373-0. Epub 2014 Jun 3.
8
Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis.凝胶原纤维蛋白淀粉样变性症致早老和进行性双侧性面瘫。
Plast Reconstr Surg. 2011 Jun;127(6):2342-2351. doi: 10.1097/PRS.0b013e318213a0a2.
9
Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the p.Asp187Tyr mutation in the GSN gene.一个患有芬兰型淀粉样变性且GSN基因存在p.Asp187Tyr突变的法国家族中的心脏传导改变。
Muscle Nerve. 2006 Jan;33(1):113-9. doi: 10.1002/mus.20448.
10
Destabilization of Ca2+-free gelsolin may not be responsible for proteolysis in Familial Amyloidosis of Finnish Type.无钙凝溶胶蛋白的不稳定可能与芬兰型家族性淀粉样变性中的蛋白水解无关。
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2334-9. doi: 10.1073/pnas.041452598. Epub 2001 Feb 20.